Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,030
Closed -$967K 817
2025
Q3
$967K Sell
51,030
-7,641
-13% -$129K ﹤0.01% 628
2025
Q2
$549K Buy
58,671
+39,991
+214% +$365K ﹤0.01% 646
2025
Q1
$202K Buy
18,680
+139
+0.7% +$1.83K ﹤0.01% 696
2024
Q4
$259K Sell
18,541
-14,919
-45% -$214K ﹤0.01% 694
2024
Q3
$531K Sell
33,460
-3,854
-10% -$69.2K ﹤0.01% 669
2024
Q2
$681K Buy
37,314
+19,827
+113% +$325K ﹤0.01% 628
2024
Q1
$288K Hold
17,487
﹤0.01% 742
2023
Q4
$310K Buy
+17,487
New +$176K ﹤0.01% 666

Other funds holding ZIMV

Boston Partners's ZIMV Position: Q4 2025 in Review

Boston Partners sold out of ZimVie (ZIMV) in Q4 2025, closing a stake of 51,030 shares — an estimated $967K sold.

Boston Partners first reported a position in ZIMV in Q4 2023 and held it in 8 quarters. The position peaked at $967K in Q3 2025. 1 fund tracked by Wall St. Rank holds ZIMV as of Q4 2025.

  • Boston Partners reported no remaining ZimVie position as of Q4 2025 after selling out during the quarter.
  • Boston Partners sold 51,030 ZimVie shares in Q4 2025, an estimated $967K.
  • Boston Partners first reported a position in ZimVie in Q4 2023 and held it in 8 quarters.
  • Boston Partners's ZimVie position peaked at $967K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held ZimVie as of Q4 2025.

Based on Boston Partners's 13F filing for Q4 2025, filed 13 Feb 2026.